| Literature DB >> 28424791 |
Yange Liu1, Lanzhou Li1, Shengshu An1, Yuanzhu Zhang1, Shiwei Feng1, Lu Zhao1, Lirong Teng1, Di Wang1.
Abstract
Antrodia cinnamomea, a folk medicinal mushroom, has numerous biological effects. In this study, we aim to assess whether the antifatigue effects of A. cinnamomea mycelia (AC) and its underlying mechanisms are related to oxidative stress signaling using behavioral mouse models and biochemical indices detection. Mice were orally treated with AC at doses of 0.1, 0.3, and 0.9 g/kg for three weeks. AC had no effect on the spontaneous activities of mice indicating its safety on central nervous system. Furthermore, results obtained from weight-loaded forced swimming test, rotary rod test, and exhausted running test confirmed that AC significantly enhanced exercise tolerance of mice. Biochemical indices levels showed that these effects were closely correlated with inhibiting the depletion of glycogen and adenosine triphosphate stores, regulating oxidative stress-related parameters (superoxide dismutase, glutathione peroxidase, reactive oxygen species, and malondialdehyde) in serum, skeletal muscle, and liver of mice. Moreover, the effects of AC may be related with its regulation on the activations of AMP-activated protein kinase, protein kinase B, and mammalian target of rapamycin in liver and skeletal muscle of mice. Altogether, our data suggest that the antifatigue properties of AC may be one such modulation mechanism via oxidative stress-related signaling in mice.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28424791 PMCID: PMC5382311 DOI: 10.1155/2017/9374026
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1The experimental protocol and drug administration.
Figure 2Three-week AC treatment brought no significant differences in movements (a) but significantly prolonged exhaustive time in (b) running, (c) swimming, and (d) rotating tests. The data were expressed as means ± SEM (n = 24) and analyzed using a one-way ANOVA. P < 0.05 and P < 0.01 in a comparison with the control mice.
Figure 3Three-week AC treatment reduced the activities of sera (a) ALT and (b) AST of mice with or without 60 min swimming. The data are expressed as means ± SEM (n = 12) and analyzed using a one-way ANOVA. P < 0.05 in a comparison with the control mice without swimming; #P < 0.05 in a comparison with the control mice with 60 min swimming.
Figure 4Three-week AC treatment enhanced the levels of (a) hepatic glycogen and (b) skeletal muscle glycogen of mice with or without 60 min swimming. The data are expressed as means ± SEM (n = 12) and analyzed using a one-way ANOVA. P < 0.05 in a comparison with the control mice without swimming; #P < 0.05 in a comparison with the control mice with 60 min swimming; ∧P < 0.05 in a comparison between the same agent treated mice with and without 60 min swimming.
AC regulated the levels of ATP in the serum, liver, and skeletal muscle of mice with and without swimming.
| CTRL | AC (0.1 g/kg) | AC (0.3 g/kg) | AC (0.9 g/kg) | ||
|---|---|---|---|---|---|
| Serum ( | Without swimming | 59.32 ± 6.02 | 69.36 ± 4.62 | 78.36 ± 4.81 | 75.35 ± 4.72 |
| With swimming | 61.47 ± 5.86 | 86.7 ± 8.66#∧ | 89.33 ± 7.36# | 97.11 ± 5.38##∧∧ | |
| Liver ( | Without swimming | 67.35 ± 2.67 | 71.54 ± 4.79 | 80.64 ± 3.51 | 86.48 ± 4.4 |
| With swimming | 86.01 ± 0.48∧∧ | 93.6 ± 10.52∧∧ | 92.41 ± 14.34∧ | 94.44 ± 18.89∧ | |
| Skeletal muscle (nmol/gprot) | Without swimming | 18.06 ± 0.57 | 19.15 ± 0.53 | 20.55 ± 0.5 | 21.96 ± 0.64 |
| With swimming | 19.1 ± 0.55 | 21.9 ± 0.33#∧ | 20.54 ± 0.33# | 24.21 ± 0.39##∧ |
The data are expressed as means ± SEM (n = 12) and analyzed using a one-way ANOVA. P < 0.05 and P < 0.01 in a comparison with the control mice without swimming; #P < 0.05 and ##P < 0.01 in a comparison with the control mice with 60 min swimming; ∧P < 0.05 and ∧∧P<0.01 in a comparison between the same agent treated mice with and without 60 min swimming.
AC regulated the levels of ROS, MDA, GSH-Px, and SOD in the serum, liver, and skeletal muscle of mice with and without swimming.
| CTRL | AC (0.1 g/kg) | AC (0.3 g/kg) | AC (0.9 g/kg) | |
|---|---|---|---|---|
| Serum | ||||
| Without swimming | ||||
| MDA (nmol/mL) | 0.69 ± 0.07 | 0.47 ± 0.05 | 0.5 ± 0.05 | 0.58 ± 0.04 |
| GSH-Px (U/mL) | 39.93 ± 3.03 | 45.61 ± 1.97 | 47.07 ± 2.26 | 45 ± 2.87 |
| SOD (U/mL) | 33.26 ± 1.91 | 36.21 ± 1.08 | 41.27 ± 1.87 | 46.36 ± 0.86 |
| With swimming | ||||
| MDA (nmol/mL) | 0.90 ± 0.08∧∧ | 0.65 ± 0.08#∧∧ | 0.67 ± 0.05#∧∧ | 0.80 ± 0.05∧∧ |
| GSH-Px (U/mL) | 42.75 ± 2.14 | 51.64 ± 1.79##∧ | 48.79 ± 1.38# | 45.43 ± 1.22 |
| SOD (U/mL) | 33.13 ± 1.58 | 35.80 ± 1.67 | 39.20 ± 1.85# | 42.93 ± 1.07## |
|
| ||||
| Liver | ||||
| Without swimming | ||||
| ROS (FI/mgprot) | 222.90 ± 22.54 | 156.75 ± 26.84 | 128.11 ± 25.74 | 152.00 ± 19.32 |
| MDA (nmol/mgprot) | 0.78 ± 0.02 | 0.71 ± 0.03 | 0.68 ± 0.02 | 0.71 ± 0.01 |
| GSH-Px (U/mgprot) | 290.39 ± 17.32 | 323.8 ± 24.09 | 316.55 ± 13.23 | 322.83 ± 17.3 |
| SOD (U/mgprot) | 7.66 ± 0.41 | 8.4 ± 0.4 | 8.64 ± 0.43 | 8.65 ± 0.25 |
| With swimming | ||||
| ROS (FI/mgprot) | 290.67 ± 33.92∧ | 196.83 ± 36.54 | 183.88 ± 22.21#∧ | 187.29 ± 39.29# |
| MDA (nmol/mgprot) | 0.83 ± 0.04 | 0.75 ± 0.03 | 0.74 ± 0.03 | 0.73 ± 0.03# |
| GSH-Px (U/mgprot) | 282.31 ± 17.4 | 335.64 ± 21.31 | 333.72 ± 19.96 | 348.28 ± 18.36# |
| SOD (U/mgprot) | 7.47 ± 0.37 | 8.21 ± 0.38 | 8.29 ± 0.44 | 8.60 ± 0.28# |
|
| ||||
| Skeletal muscle | ||||
| Without swimming | ||||
| ROS (FI/mgprot) | 106.89 ± 6.67 | 95.4 ± 6.18 | 83.1 ± 2.49 | 90.20 ± 0.71 |
| MDA (nmol/mgprot) | 9.63 ± 0.48 | 7.43 ± 0.53 | 7.56 ± 0.24 | 7.46 ± 0.21 |
| GSH-Px (U/mgprot) | 79.42 ± 1.75 | 85.19 ± 4.06 | 90.95 ± 1.95 | 91.57 ± 0.88 |
| SOD (U/mgprot) | 78.04 ± 1.22 | 80.11 ± 2.51 | 84.77 ± 1.43 | 83.36 ± 2.93 |
| With swimming | ||||
| ROS (FI/mgprot) | 111.78 ± 5.21 | 96.60 ± 5.18 | 95.88 ± 3.73# | 97.22 ± 3.79#∧ |
| MDA (nmol/mgprot) | 9.13 ± 0.41 | 7.41 ± 0.45# | 7.63 ± 0.33# | 8.39 ± 0.33 |
| GSH-Px (U/mgprot) | 65.52 ± 3.19∧ | 76.61 ± 4.73∧ | 82.05 ± 4.8#∧ | 87.89 ± 6.17# |
| SOD (U/mgprot) | 78.31 ± 1.59 | 93.35 ± 3.5##∧ | 83.56 ± 1.32 | 86.81 ± 1.55# |
The data are expressed as means ± SEM (n = 12) and analyzed using a one-way ANOVA. P < 0.05, P < 0.01, and P < 0.001 compared with control mice without swimming; #P < 0.05 and ##P < 0.01 compared with control mice with 60 min swimming; ∧P < 0.05 and ∧∧P<0.01 in a comparison between the same agent treated mice with and without 60 min swimming.
Figure 5Three-week AC treatment upregulated the levels of phosphor-Akt and phosphor-AMPK and suppressed the expression of phosphor-mTOR in (a) livers and (b) skeletal muscle of mice with 60 min swimming. The data on quantified protein expression were normalized to the expressions of GAPDH. The data are expressed as means ± SEM (n = 6) and analyzed using a one-way ANOVA P < 0.05, P < 0.01, and P < 0.001 in a comparison with the control mice.